Eric Schlorff - 23 Jun 2023 Form 4 Insider Report for SeaStar Medical Holding Corp (ICU)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Schlorff
Issuer symbol: ICU
Transactions as of: 23 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2023, 16:01:51 UTC
Previous filing: 10 Apr 2023
Next filing: 28 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICU	Common Stock, par value $0.0001 per share	Award	$0	+417,386	+157%	$0.000000	682,399	23 Jun 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ICU	Stock Option (Right to Buy)						99,724	23 Jun 2023	Common Stock	99,724	$1.84	Direct	F3
holding	ICU	Stock Option (Right to Buy)						17,986	23 Jun 2023	Common Stock	17,986	$10.00	Direct	F4
holding	ICU	Stock Option (Right to Buy)						83,985	23 Jun 2023	Common Stock	83,985	$0.5300	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents fully vested shares of common stock issued to the Reporting Person pursuant to the Issuer's equity incentive plan. Such fully vested shares of common stock are issued as payment for the occurrence of an exit event bonus under that certain Transaction Bonus Agreement, dated as of December 23, 2021, as amended, between the Issuer and the Reporting Person.
F2	Includes 66,483 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.
F3	All options reported herein will vest, subject to continued service, on April 6, 2024.
F4	These options are fully vested.
F5	The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.